(Q47688440)

English

p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

bladder carcinoma

1 reference

based on heuristic

inferred from title

Gabriel Capella

9

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Xavier Castellsagué

object named as

Xavier Castellsagué

4

0 references

author name string

Xavier Garcia del Muro

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Enric Condom

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Francesc Vigués

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Agnès Figueras

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Josep Muñoz

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Judit Solá

7

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Teresa Soler

8

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Josep R Germà

10

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

100

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

1859-1867

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

9

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

A model for p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

21 January 2018

Selective bladder preservation by combination treatment of invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell-cycle arrest versus cell death in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic determinants of p53-induced apoptosis and growth arrest

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Can p53 help select patients with invasive bladder cancer for bladder preservation?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20200

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20200

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15112266

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47688440&oldid=1506690936"